Correlation Between Revelation Biosciences and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revelation Biosciences and ZyVersa Therapeutics, you can compare the effects of market volatilities on Revelation Biosciences and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and ZyVersa Therapeutics.
Diversification Opportunities for Revelation Biosciences and ZyVersa Therapeutics
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Revelation and ZyVersa is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Revelation Biosciences and ZyVersa Therapeutics
Given the investment horizon of 90 days Revelation Biosciences is expected to under-perform the ZyVersa Therapeutics. In addition to that, Revelation Biosciences is 1.37 times more volatile than ZyVersa Therapeutics. It trades about -0.11 of its total potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.11 per unit of volatility. If you would invest 107.00 in ZyVersa Therapeutics on December 30, 2024 and sell it today you would lose (46.00) from holding ZyVersa Therapeutics or give up 42.99% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Revelation Biosciences vs. ZyVersa Therapeutics
Performance |
Timeline |
Revelation Biosciences |
ZyVersa Therapeutics |
Revelation Biosciences and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Revelation Biosciences and ZyVersa Therapeutics
The main advantage of trading using opposite Revelation Biosciences and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.Revelation Biosciences vs. Virax Biolabs Group | Revelation Biosciences vs. Kiora Pharmaceuticals | Revelation Biosciences vs. ZyVersa Therapeutics | Revelation Biosciences vs. Sonnet Biotherapeutics Holdings |
ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Fundamental Analysis View fundamental data based on most recent published financial statements |